Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 2,277Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3HARROW EYE

02 7MYLAN SPECIALITY LP

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 7795316

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code : U-1082

Delist Requested :

Patent Use Description : USE OF A COMBINATION O...

Patent Expiration Date : 2028-08-03

blank

02

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 8101582

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code : U-1082

Delist Requested :

Patent Use Description : USE OF A COMBINATION O...

Patent Expiration Date : 2027-12-19

blank

03

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

DEXAMETHASONE; TOBRAMYCIN

US Patent Number : 8450287

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 50818

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-19

blank

04

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 8664187

Drug Substance Claim :

Drug Product Claim :

Application Number : 201688

Patent Use Code : U-909

Delist Requested :

Patent Use Description : TREATMENT OF CYSTIC FI...

Patent Expiration Date : 2025-06-20

blank

05

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 8869794

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code : U-909

Delist Requested :

Patent Use Description : TREATMENT OF CYSTIC FI...

Patent Expiration Date : 2028-09-12

blank

06

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 10207066

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code : U-909

Delist Requested :

Patent Use Description : TREATMENT OF CYSTIC FI...

Patent Expiration Date : 2030-11-04

blank

07

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 11484671

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code : U-909

Delist Requested :

Patent Use Description : TREATMENT OF CYSTIC FI...

Patent Expiration Date : 2024-11-07

blank

08

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : RE47526

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-04-09

blank

09

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 7559325

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-10-27

blank

10

arrow
Antibody Engineering
Not Confirmed
arrow
Antibody Engineering
Not Confirmed

TOBRAMYCIN

US Patent Number : 7516741

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 201688

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2024-01-11

blank